NICE rejects trastuzumab emtansine for use on NHS

BMJ. 2015 Dec 16:351:h6837. doi: 10.1136/bmj.h6837.
No abstract available

Publication types

  • News

MeSH terms

  • Antineoplastic Agents / economics*
  • Antineoplastic Agents / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Female
  • Financing, Organized / methods
  • Health Services Accessibility / economics
  • Humans
  • State Medicine / economics
  • Trastuzumab / economics*
  • Trastuzumab / therapeutic use

Substances

  • Antineoplastic Agents
  • Trastuzumab